Skip to main content
Zoe Draelos, MD, Dermatology, High Point, NC, High Point Medical Center

ZoeDianaDraelosMD

Dermatology High Point, NC

Dermatologic Surgery, Dermatopathology, Pediatric Dermatology

Consulting Professor in the Department of Dermatology, Duke University School of Medicine

Are you Dr. Draelos?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 43 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Zoe Draelos, MD is a board certified dermatologist in High Point, North Carolina. She is currently licensed to practice medicine in North Carolina and Arizona. She is affiliated with High Point Medical Center and Novant Health Thomasville Medical Center.

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonResidency, Dermatology, 1984 - 1987
  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonInternship, Internal Medicine, 1983 - 1984
  • University of Arizona College of Medicine
    University of Arizona College of MedicineClass of 1983

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1987 - Present
  • NC State Medical License
    NC State Medical License 1987 - 2024
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020
  • The Role of ’Biotics in SkincareApril 2020

Press Mentions

  • Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020
    Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020December 9th, 2020
  • Arcutis to Host Virtual Investor Day on Wednesday, December 9, 2020
    Arcutis to Host Virtual Investor Day on Wednesday, December 9, 2020December 2nd, 2020
  • Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology
    Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic DermatologyOctober 26th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations